Serina Therapeutics (SER) Research & Development (2018 - 2026)
Serina Therapeutics (SER) posted Research & Development of $3.4 million for Q4 2025, down 6.85% sequentially from $3.7 million in Q3 2025, and up 43.81% YoY from $2.4 million in Q4 2024.
Serina Therapeutics (SER) Research & Development (2018 - 2026) Analysis & Trends
Serina Therapeutics has reported Research & Development for 8 years, with the latest figure at $3.4 million in Q4 2025.
- Quarterly Research & Development rose 43.81% year-over-year to $3.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.2 million (up 75.87% YoY) and the FY2025 annual result came in at $13.2 million, up 75.87% from the prior year.
- Research & Development retreated to $3.4 million in Q4 2025 per SER's latest filing, from $3.7 million in the prior quarter.
- Over five years, Research & Development peaked at $3.7 million in Q3 2025 and troughed at $162000.0 in Q3 2022.
- A 5-year average of $1.3 million and a median of $542000.0 in 2021 frame the typical range for Research & Development.
- The sharpest annual moves came in 2021 and 2023: Research & Development plunged 73.46% in 2021, then surged 336.06% in 2023.
- Over 5 years, Research & Development stood at $376000.0 in 2021, then sank by 44.68% to $208000.0 in 2022, then surged by 336.06% to $907000.0 in 2023, then jumped by 160.75% to $2.4 million in 2024, then soared by 43.81% to $3.4 million in 2025.
- According to Business Quant data, Research & Development over the past three periods registered $3.4 million, $3.7 million, and $3.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 651.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 612.28 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 413.13 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 210.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 97.90 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -588.31 Mn |
| 10 | Serina Therapeutics | 43.17 Mn | 20.15 Mn | - | 3.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.82 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Sep 30, 2025 | 3.65 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 2.95 Mn |
| Dec 31, 2024 | 2.37 Mn |
| Sep 30, 2024 | 2.42 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 1.11 Mn |
| Dec 31, 2023 | 907,000.00 |
| Sep 30, 2023 | 603,000.00 |
| Jun 30, 2023 | 479,000.00 |
| Mar 31, 2023 | 399,000.00 |
| Dec 31, 2022 | 208,000.00 |
| Sep 30, 2022 | 162,000.00 |
| Jun 30, 2022 | 259,000.00 |
| Mar 31, 2022 | 396,000.00 |
| Dec 31, 2021 | 376,000.00 |
| Sep 30, 2021 | 275,000.00 |
| Jun 30, 2021 | 481,000.00 |